Table 1 Baseline characteristics of imaging subcohort
|  | UK biobank cohort baseline visit (2008–2010) | Imaging subcohort baseline visit (2008–2010) | Imaging subcohort first imaging visit (2014+) |
|---|---|---|---|
n | 502,604 | 40,346 | 40,346 |
Age (years) | 56.3 (8.1) | 55.0 (7.5) | 63.7 (7.6) |
% Females | 54.40% | 51.70% | 51.70% |
BMI | 27.43 (4.80) | 26.54 (4.40) | 26.61 (4.80) |
Smoker (current) | 10.50% | 6.36% | 3.55% |
Smoker (previous) | 34.50% | 32.96% | 33.84% |
Comorbidities | |||
% Hypertension | 7.88% | 6.44% | 16.83% |
% T1D | 0.42% | 0.26% | 0.38% |
% T2D | 1.83% | 1.57% | 3.86% |
% CKD | 0.13% | 0.71% | 1.96% |
% Dorsalgia | 15.56% | 10.31% | 15.01% |
% Scoliosis | 0.81% | 0.32% | 0.49% |
% Ankylosing Spondylitis | 0.41% | 0.21% | 0.32% |
% Kyphosis | 0.19% | 0.02% | 0.05% |
% Spondylosis | 0.07% | 0.03% | 0.04% |
% Knee Osteoarthritis | 8.72% | 1.38% | 3.96% |
% Hip Osteoarthritis | 5.07% | 0.20% | 0.62% |
% DISH EHR | 0.0085% | 0.0024% | 0.0024% |
Biomarkers | |||
Glucose (mmol/L) | 5.12 (1.24) | 4.99 (1.24) | Â |
HbA1c (mmol/mol) | 35.2 (6.78) | 35.0 (6.78) | Â |
Trig (mmol/L) | 1.75 (1.45) | 1.65 (1.03) | Â |
LDL (mmol/L) | 3.56 (0.87) | 3.58 (0.87) | Â |
HDL (mmol/L) | 1.45 (0.38) | 1.47 (0.38) | Â |
Cholesterol (mmol/L) | 5.69 (1.14) | 5.72 (1.14) | Â |
Serum Phosphate (mmol/L) | 1.16 (0.16) | 1.16 (0.16) | Â |
Serum Calcium (mmol/L) | 2.38 (0.09) | 2.38 (0.09) | Â |
Serum Creatinine (umol/L) | 72.31 (18.55) | 72.34(18.55) | Â |
Cystatin C (mg/L) | 0.91 (0.18) | 0.87 (0.12) | Â |
VitD3 (nmol/L) | 48.61 (21.11) | 49.73 (21.11) | Â |